Source: EuroFlu, full page:
Full report:



'In the Netherlands, a hospitalised immunocompromised patient was identified carrying an oseltamivir resistant A(H1N1)pdm09 virus with the H275Y amino acid substitution.

'This resistant variant emerged during oseltamivir therapy and was detected shortly after oseltamivir was stopped and before zanamivir therapy was started.

'The patient was also treated with antibiotics for pneumoniae due to Haemophilus influenzae, thereof improved rapidly and was discharged 20 days after onset of respiratory symptoms.'